A Large Cohort Study of 18F Fluoro-Deoxy-Glucose Uptake in Normal Spinal Cord: Quantitative Assessment of the Contamination From Adjacent Vertebral Marrow Uptake and Validity of Normalizing the Cord Uptake Against the Lumbar Thecal Sac

被引:7
作者
Patel, Neema J. [1 ]
Gupta, Vivek [1 ]
Vibhute, Prasanna G. [1 ]
Jain, Manoj K. [1 ]
Accurso, Joseph M. [1 ]
机构
[1] Mayo Clin, Dept Radiol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
关键词
F-18 fluoro-deoxy-glucose (F-18-FDG); positron emission tomography; spinal cord; SUV; cord to background ratio; vertebral marrow; POSITRON-EMISSION-TOMOGRAPHY; RADIATION MYELOPATHY; FDG UPTAKE; METASTASIS; CARCINOMA; PET/CT;
D O I
10.1097/RCT.0000000000000479
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: This study aimed (1) to assess the influence of age, sex, blood glucose, and body mass index on the F-18 fluoro-deoxy-glucose ((1)8F-FDG) uptake in normal spinal cord; (2) to quantitatively evaluate contamination of the spinal cord SUVmax by the adjacent vertebral marrow activity; and (3) to investigate the validity of normalizing spinal cord SUVmax against lumbar thecal sac SUVmax. Methods: Two hundred positron emission tomography-computed tomography examinations of subjects with normal spinal cordwere retrospectively reviewed. SUVmax of spinal cord and vertebral bodywas obtained atC2, C5, T6, T12, and L3 levels. Pearson correlation coefficients (r) were obtained at each level between spinal cord SUVmax and vertebral marrow SUVmax, age, body mass index, and blood glucose. Cord to background ratio (CTB) was calculated as the ratio between SUVmax of spinal cord and SUVmax of L3 thecal sac. The coefficient of variation (CV) of spinal cord SUVmax was compared with the CV of CTB. Results: Spinal cord SUVmax was highest at C2 (mean, 1.76) and lowest at T6 (mean, 1.37) with SD of 0.32 to 0.36 SUV. Sex (P > 0.45), age (r: -0.25 to -0.06), body mass index (r: 0.19 to 0.27), and blood glucose (r: -0.17 to 0.22) had no impact on the spinal cord SUVmax. A moderate to strong positive correlation (r: 0.66-0.80) was found between spinal cord SUVmax and the corresponding vertebral marrow SUVmax. The CV of CTB was greater (0.28-0.32) than the CV of spinal cord SUVmax (0.19-0.25) across all levels. Conclusions: Of the variables studied, only contamination from adjacent vertebral marrow activity significantly affected the SUVmax of spinal cord. This contamination should be corrected for when reporting spinal cord FDG uptake. Lumbar thecal sac is not a valid reference for normalizing spinal cord FDG uptake.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 22 条
[1]   Physiological 18F-FDG uptake by the spinal cord: is it a point of consideration for cancer patients? [J].
Amin, Amr ;
Rosenbaum, Sandra J. ;
Bockisch, Andreas .
JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (03) :609-615
[2]   Tumor Quantification in Clinical Positron Emission Tomography [J].
Bai, Bing ;
Bading, James ;
Conti, Peter S. .
THERANOSTICS, 2013, 3 (10) :787-801
[3]  
Bhatt G, 2013, AM J NUCL MED MOLEC, V3, P317
[4]   Radiation myelopathy visualized as increased FDG uptake on positron emission tomography [J].
Chamroonrat, W ;
Posteraro, A ;
El-Haddad, G ;
Zhuang, HM ;
Alavi, A .
CLINICAL NUCLEAR MEDICINE, 2005, 30 (08) :560-560
[5]  
Chong Ari, 2013, Chonnam Med J, V49, P38, DOI 10.4068/cmj.2013.49.1.38
[6]  
DICHIRO G, 1983, J COMPUT ASSIST TOMO, V7, P937
[7]   Pattern of 18F-FDG Uptake in the Spinal Cord in Patients With Non-Central Nervous System Malignancy [J].
Do, Bao H. ;
Mari, Carina ;
Tseng, Jeffrey R. ;
Quon, Andrew ;
Rosenberg, Jarrett ;
Biswal, Sandip .
SPINE, 2011, 36 (21) :E1395-E1401
[8]   PET identifies transitional metabolic change in the spinal cord following a subthreshold dose of irradiation [J].
Ésik, O ;
Emri, M ;
Szakall, S ;
Herzog, H ;
Sáfrány, G ;
Lengyel, E ;
Boér, A ;
Liszkay, G ;
Trón, L ;
Lengyel, Z ;
Repa, I .
PATHOLOGY & ONCOLOGY RESEARCH, 2004, 10 (01) :42-46
[9]   Radiation myelopathy with partial functional recovery:: PET evidence of long-term increased metabolic activity of the spinal cord [J].
Ésik, O ;
Emri, M ;
Csornai, M ;
Kásler, M ;
Godény, M ;
Trón, L .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 163 (01) :39-43
[10]   [18F]-Fluorodeoxyglucose-Positron Emission Tomography in Patients With Active Myelopathy [J].
Flanagan, Eoin P. ;
Hunt, Christopher H. ;
Lowe, Val ;
Mandrekar, Jay ;
Pittock, Sean J. ;
O'Neill, Brian Patrick ;
Keegan, B. Mark .
MAYO CLINIC PROCEEDINGS, 2013, 88 (11) :1204-1212